Therefore, we choose the pancreatic cancer patient-derived xenograft (PDX) models with the high expression of AXL in both cancer cell and macrophage to test whether GAS6-CAR-T cells can also eliminate cancer cells and macrophages in vivo. Here, AXL is linked to pancreatic neoplasm.